After extremely weak performance in early 2014, the biotechnology industry understandably dropped off the radar of most investors. For those who haven’t been watching, the industry has quietly been making a comeback. For risk-tolerant investors, now could be the time to give it a second look. (For more, see: The Ups and Downs of Biotechnology.)

As you can see from the chart of the SPDR S&P Biotech Index ETF (XBI), the sector has been trading within an extremely strong uptrend since 2010. This year’s extremely wide range of $171.47 in February to the low of $118 in April is a clear example of the type of volatility that traders in this industry can expect so proceed with caution. (For more, see: The Industry Handbook: Biotechnology.)

Biotech Investing Risks

Investing in biotechnology comes with a host of risks. In most cases, these companies can live or die based on results of drug trials. As investors in Dendreon Corp. (DNDN) are painfully aware, one day you can be on top of the world, and the next you can see your investment halved — or worse. The 10-year weekly chart (below) is a clear example of how important timing can be. Investment experience, risk tolerance and capital protection are key when it comes to investing in biotechnology, and it can be extremely costly for those who venture in unaware of the risk. (For more, see: A Primer on the Biotech Sector.)

Key Players In Biotechnology

Traders who want to invest in biotech companies directly but don’t know where to start should consider checking out the top holdings of the SPDR S&P Biotech ETF. The top-five holdings are shown in the table below:


Weighting (%)

Puma Biotechnology Inc. (PBYI)


InterMune Inc. (ITMN)


Anacor Pharmaceuticals Inc. (ANAC)


Exact Sciences Corp. (EXAS)


Gilead Sciences Inc. (GILD)



As discussed above, biotech companies generally live or die based on trial results. There is no better example of this so far in 2014 than Puma Biotechnology, which shot up 295% on July 23 when the company announced news from a Phase III trial of its experimental breast cancer drug. This type of move can turn investors such as Alan Auerbach, the company’s founder, into a billionaire overnight. It's the type of move that most biotech investors dream of but is the exception rather than the rule. The question now for most investors is whether the company is now positioned for a buyout, which would send the stock even higher. (For related reading, see: 8 Stages of New Drug Development.)

The Bottom Line

When it comes to investing in biotechnology, it's important to understand the risk. Granted, there are few industries in which companies can go from relatively unknowns to billion-dollar enterprises overnight. This definitely has its allure, but remember that fortunes can be made and lost in a blink so be sure to tread carefully. For those who want to gain exposure to the sector, one popular tool could be the XBI ETF. For those who want to invest in specific biotechs, it may be wise to check out the components of the ETF for ideas. (For more, see: Investing In The Biotech Sector and How Gilead Became A Big Name In Biotech.)

Related Articles
  1. Stock Analysis

    How Gilead Sciences Became A Big Name In Biotech

    How does a company start with an unfortunate bout of dengue fever and grow to be a multibillion dollar corporation?
  2. Mutual Funds & ETFs

    Mutual Funds Are Not FDIC Insured: Here Is Why

    Find out why mutual funds are not insured by the FDIC, including why the FDIC was created and how to minimize your risk with educated mutual fund investments.
  3. Professionals

    How to Sell Mutual Funds to Your Clients

    Learn about the various talking points you should cover when discussing mutual funds with clients and how explaining their benefits can help you close the sale.
  4. Mutual Funds & ETFs

    Top Three Transportation ETFs

    These three transportation funds attract the majority of sector volume.
  5. Professionals

    Tax Efficient Strategies for Mutual Funds

    Before you sell mutual fund shares, consider these tax strategies first.
  6. Stock Analysis

    5 Cheap Dividend Stocks for a Bear Market

    Here are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
  7. Professionals

    Fund and ETF Strategies for Volatile Markets

    Looking for short-term fixes in reaction to market volatility? Here are a few strategies — and their downsides.
  8. Investing Basics

    Tops Tips for Trading ETFs

    A look at two different trading strategies for ETFs - one for investors and the other for active traders.
  9. Investing

    How to Win More by Losing Less in Today’s Markets

    The further you fall, the harder it is to climb back up. It’s a universal truth that is painfully apparent in the investing world.
  10. Fundamental Analysis

    Use Options Data To Predict Stock Market Direction

    Options market trading data can provide important insights about the direction of stocks and the overall market. Here’s how to track it.
  1. Can your car insurance company check your driving record?

    While your auto insurance company cannot pull your full motor vehicle report, or MVR, it does pull a record summary that ... Read Full Answer >>
  2. How often do mutual funds pay capital gains?

    The frequency with which mutual funds pay capital gains varies. However, funds that generate a profit within a given year ... Read Full Answer >>
  3. How often do mutual funds report their holdings?

    The Securities and Exchange Commission (SEC) requires mutual funds to report complete lists of their holdings on a quarterly ... Read Full Answer >>
  4. How can I find tax-exempt mutual funds?

    Tax-exempt mutual funds can be found at many prominent investment firms. Most mutual funds offer a variety of investment ... Read Full Answer >>
  5. How do mutual funds split?

    Mutual funds split in the same way that individual stocks split, but less often. Like a stock split, mutual fund splits do ... Read Full Answer >>
  6. Can mutual funds invest in IPOs?

    Mutual funds can invest in initial public offerings (IPOS). However, most mutual funds have bylaws that prevent them from ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!